About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Not Yet RecruitingNCT06619743

HPV Infection and Vaginal Microecology in Immunosuppressed Women

This study intends to establish a screening cohort for HPV infection and related tumors in areas with high incidence of HIV infection, explore the screening of cervical cancer and anal cancer and the ...

Lead sponsor: Lan Zhu•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Roujie Huang

CONTACT

+8618373153750 [email protected]

Lan Zhu, MD

CONTACT

[email protected]

Sponsors

Lead Sponsor

Lan Zhu

Age

18 - 75 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•HIV positive female, ≥18 years old
•HIV infection is sexually transmitted
•Have an intact cervix
•Have not received cervical cancer screening in the past 1 year
•No previous treatment for CIN/cervical cancer
•No clinical pregnancy symptoms

Exclusion Criteria

•Women who have had a previous cervical resection
•Unable to complete all screening processes independently
•Unable or unwilling to accept follow-up
•For subjects in vaginal microecology studies, women who used antibiotics within 2 weeks before collecting vaginal secretions, had sexual intercourse within 3 days, or used vaginal medication or vaginal douching within 48 hours need to be further excluded.

Related studies

DESTINY-PANTUMOUR04

NCT07124000 · Adenocarcinoma (NOS), Anal Cancer, and more

RECRUITINGPhase 1/2

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

NCT06814496 · Melanoma, Medullary Thyroid Cancer, and more

RECRUITINGPhase 2

PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer

NCT06157151 · Cervical Cancer, HPV-Related Carcinoma, and more

RECRUITINGPhase 4

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

NCT06952660 · Cervical Cancer

RECRUITINGPhase 3

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

NCT06694805 · HIV Infections

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 1, 2024Terms

Trial snapshot

StatusNOT_YET_RECRUITING

Phase—

Enrollment10,000

Start dateOct 2024

Last updatedOct 1, 2024

Condition

HIV Infections HPV Infection Cervical Cancer Anal Cancer

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 1, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions